StockNews.com Upgrades Charles River Laboratories International (NYSE:CRL) to Buy
StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Other equities analysts have also recently issued research reports about the stock. Citigroup raised their target price on shares of Charles River Laboratories International from $215.00 to […]